Efficacy of four different regimens in 64 mantle-cell lymphoma cases : clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypesTEODOROVIC, I; PITTALUGA, S; KLUIN-NELEMANS, J. C et al.Journal of clinical oncology. 1995, Vol 13, Num 11, pp 2819-2826, issn 0732-183XArticle

Medical fellowship programme within the Gynaecological Cancer Group of the European Organisation for Research and treatment of CancerWAGENAAR, H. C; TRIMBOS, J. B. M. Z; TEODOROVIC, I et al.Gynecologic and obstetric investigation. 2004, Vol 57, Num 2, pp 66-71, issn 0378-7346, 6 p.Article

Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphomaMEERWALDT, J. H; CARDE, P; HAGENBEEK, A et al.Annals of oncology. 1997, Vol 8, pp 67-70, issn 0923-7534, SUP1Conference Paper

Clinical analysis of 670 cases in two trials of the European organization for the research and treatment of cancer lymphoma cooperative group subtyped according to the revised European-American classification of lymphoid neoplasms : A comparison with the working formulationPITTALUGA, S; BIJNENS, L; TEODOROVIC, I et al.Blood. 1996, Vol 87, Num 10, pp 4358-4367, issn 0006-4971Article

Alterations in the p53 pathway and prognosis in advanced ovarian cancer : A multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865)GREEN, J. A; BERNS, E. M. J. J; TJALMA, W et al.European journal of cancer (1990). 2006, Vol 42, Num 15, pp 2539-2548, issn 0959-8049, 10 p.Article

Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer GroupAAPRO, M. S; VAN WIJK, F. H; FRANCHI, M et al.Annals of oncology. 2003, Vol 14, Num 3, pp 441-448, issn 0923-7534, 8 p.Article

Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical featuresMAES, B; ANASTASOPOULOU, A; KLUIN-NELEMANS, J. C et al.Annals of oncology. 2001, Vol 12, Num 6, pp 853-858, issn 0923-7534Article

Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix : An EORTC gynecological cancer Cooperative Group studyVERMORKEN, J. B; ZANETTA, G; DE OLIVEIRA, C. F et al.Annals of oncology. 2001, Vol 12, Num 7, pp 967-974, issn 0923-7534Article

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II. An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)REED, N. S; MANGIONI, C; TEODOROVIC, I et al.European journal of cancer (1990). 2008, Vol 44, Num 6, pp 808-818, issn 0959-8049, 11 p.Article

Long-term efficacy of the CHVmP/BV regimen used for aggressive non-Hodgkin's lymphoma in three randomised EORTC trialsMOSER, E. C; NOORDIJK, E. M; VAN GLABBEKE, M et al.European journal of cancer (1990). 2004, Vol 40, Num 4, pp 474-480, issn 0959-8049, 7 p.Article

The achievements of the EORTC Lymphoma GroupRAEMAEKERS, J; KLUIN-NELEMANS, H; TEODOROVIC, I et al.European journal of cancer. Supplement (1990). 2002, Vol 38, Num 4, pp S107-S113, issn 1359-6349Article

CHOP is the standard regimen in patients ≥ 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma : Results of a randomized study of the European Organization for Research and treatment of Cancer Lymphoma Cooperative Study GroupTIRELLI, U; ERRANTE, D; NOORDIJK, E. M et al.Journal of clinical oncology. 1998, Vol 16, Num 1, pp 27-34, issn 0732-183XArticle

Effect of PCBs on androgen production by suspension of adult rat Leydig cells in vitroKOVACEVIC, R; VOJINOVIC-MILORADOV, M; TEODOROVIC, I et al.Journal of steroid biochemistry and molecular biology. 1995, Vol 52, Num 6, pp 595-597, issn 0960-0760Article